Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma

Journal of Urology

Volumn 192, Issue 6, 2014, Pages 1822-1830

  Ishihara, Tomoaki ^a   Seki, Naohiko ^b   Inoguchi, Satoru ^a   Yoshino, Hirofumi ^a   Tatarano, Shuichi ^a   Yamada, Yasutoshi ^a   Itesako, Toshihiko ^a   Goto, Yusuke ^b   Nishikawa, Rika ^b   Nakagawa, Masayuki ^a   Enokida, Hideki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

biological markers; carcinoma; human; kidney; MIRN23 microRNA; MIRN27 microRNA; renal cell

Indexed keywords

MICRORNA; MIRNA 23B; MIRNA 27B; UNCLASSIFIED DRUG; MIRN23 MICRORNA, HUMAN; MIRN27 MICRORNA, HUMAN;

AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOLLOW UP; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RENAL CELL CARCINOMA CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ADULT; BIOSYNTHESIS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; TUMOR CELL CULTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 84913595476     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.07.001     Document Type: Article

References (31)

1. K. Gupta, J.D. Miller, and J.Z. Li Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review Cancer Treat Rev 34 2008 193
2. J. Hadoux, S. Vignot, and T. De La Motte Rouge Renal cell carcinoma: focus on safety and efficacy of temsirolimus Clin Med Insights Oncol 4 2010 143
3. S. Naito, Y. Tomita, and S.Y. Rha Kidney Cancer Working Group report Jpn J Clin Oncol 40 suppl. 2010 i51
4. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 2008 102
5. K.M. Nelson, and G.J. Weiss MicroRNAs and cancer: past, present, and potential future Mol Cancer Ther 7 2008 3655
6. H. Yoshino, H. Enokida, and T. Itesako Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma Cancer Sci 104 2013 1567
7. N.M. White, T.T. Bao, and J. Grigull miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation J Urol 186 2011 1077
8. R. Chhabra, R. Dubey, and N. Saini Cooperative and individualistic functions of the microRNAs in the miR-23a∼27a∼24-2 cluster and its implication in human diseases Mol Cancer 9 2010 232
9. K. Kawakami, H. Enokida, and T. Chiyomaru The functional significance of miR-1 and miR-133a in renal cell carcinoma Eur J Cancer 48 2012 827
10. Japanese Urological Association, Japanese Society of Pathology and Japan Radiological Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma 3rd ed. 1999 Kanehara Tokyo
11. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM Classification of Malignant Tumours 7th ed. 2009 Wiley-Liss New York 255
12. H. Hidaka, N. Seki, and H. Yoshino Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma Oncotarget 3 2012 44
13. Y. Yamada, H. Hidaka, and N. Seki Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma Cancer Sci 104 2013 304
14. W.K. Rathmell, and S. Chen VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment Expert Rev Anticancer Ther 8 2008 63
15. C.S. Neal, M.Z. Michael, and L.H. Rawlings The VHL-dependent regulation of microRNAs in renal cancer BMC Med 8 2010 64
16. B. Ljungberg, F.I. Alamdari, and T. Rasmuson Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy BJU Int 84 1999 405
17. X. Wu, L. Weng, and X. Li Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis PLoS One 7 2012 e35661
18. A. Gamez-Pozo, L.M. Anton-Aparicio, and C. Bayona MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients Neoplasia 14 2012 1144
19. T. Yamasaki, N. Seki, and Y. Yamada Tumor suppressive microRNA138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma Int J Oncol 41 2012 805
20. T. Yamasaki, N. Seki, and H. Yoshino MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway J Urol 190 2013 1059
21. S. Majid, A.A. Dar, and S. Saini miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer Cancer Res 72 2012 6435
22. Y.M. Youssef, N.M. White, and J. Grigull Accurate molecular classification of kidney cancer subtypes using microRNA signature Eur Urol 59 2011 721
23. J. An, H. Liu, and C.E. Magyar Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma Cancer Res 73 2013 1374
24. H. Faragalla, Y.M. Youssef, and A. Scorilas The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma J Mol Diagn 14 2012 385
25. J. Berkers, O. Govaere, and P. Wolter A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance J Urol 189 2013 1930
26. R.A. Ishteiwy, T.M. Ward, and D.M. Dykxhoorn The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells PLoS One 7 2012 e52106
27. L. Jin, O. Wessely, and E.G. Marcusson Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer Cancer Res 73 2013 2884
28. S. Minner, D. Rump, and P. Tennstedt Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma Cancer 118 2012 1268
29. D. Cohen, B. Lane, and T. Jin The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation Clin Genitourin Cancer 5 2007 264
30. G.T. Gibney, S.A. Aziz, and R.L. Camp c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma Ann Oncol 24 2013 343
31. R. Dabney, R. Devine, and N. Sein New agents in renal cell carcinoma Target Oncol 9 2014 183